Veru Inc.
VERU
Last
$2.46
Day
+1.7%
1y
-43.5%
5y
-97.1%
52w
-67.0%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
2.50
EMA 50
2.53
EMA 200
2.78
20d high
-12.0%
5y high
-99.0%
5y range
0th
Positions held
Your positionsVERU isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-30
Hold
avoid
Signal
Strong Sell
Target
$2.64
Stop
$2.24
Stop distance
8.9%
Target vs last
+7.3%
Fundamentals
| Market cap | $41.26M | Enterprise value | $18.21M | Trailing P/E | — | Forward P/E | -2.42 |
| PEG | 3.60 | Price / book | 1.45 | Beta | -1.20 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -64.5% | ROA | -54.0% | Debt / equity | 0.09 |
| Current ratio | 4.42 | Free cash flow | -$14.44M | Analyst recommendation | strong_buy | Mean target | $25.67 |
| 52w high | $7.33 | 52w low | $2.05 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$7.0M | -$2.7M | -$5.3M | $1.5M | -$7.3M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$7.7M | -$7.2M | -$5.4M | -$7.5M | -$8.0M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $16.3M | $39.4M |
| Op margin | — | — | -586.6% | -212.1% |
| Net income | -$22.7M | -$37.8M | -$93.2M | -$84.0M |
| Gross margin | — | — | 46.4% | 77.7% |
| Gross profit | — | $5.9M | $7.6M | $30.6M |
| Operating income | -$35.5M | -$37.4M | -$95.6M | -$83.5M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-02 · Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference
2026-08-17 · Veru (VERU) Q3 2026 Earnings Call Transcript
2026-08-10 · Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
2026-08-03 · Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th
2026-07-30 · Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference
Price (daily)
Full chart · RSI · MACD · patternsVERU · daily-3.2% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin